DS
SNOA icon

DRW Securities’s Sonoma Pharmaceuticals SNOA Stock Holding History

DRW Securities’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.6K Sell
12,015
-48,962
-80% -$143K ﹤0.01% 1216
2025
Q4 		$222K Buy
60,977
+43,907
+257% +$162K 0.01% 891
2025
Q3 		$66.2K Buy
+17,070
New +$67.2K ﹤0.01% 1216

Other funds holding SNOA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.73B AUM 17.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

DRW Securities's SNOA Position: Q1 2026 in Review

DRW Securities reduced its Sonoma Pharmaceuticals (SNOA) stake by 80% in Q1 2026, selling an estimated $143K and leaving 12,015 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

DRW Securities first reported a position in SNOA in Q3 2025 and has held it in 3 quarters since. The position peaked at $222K in Q4 2025. 17 funds tracked by Wall St. Rank hold SNOA as of Q1 2026.

  • DRW Securities held 12,015 shares of Sonoma Pharmaceuticals worth $25.6K as of Q1 2026.
  • DRW Securities sold 48,962 Sonoma Pharmaceuticals shares in Q1 2026, an estimated $143K.
  • Sonoma Pharmaceuticals made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #1216 holding.
  • DRW Securities first reported a position in Sonoma Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • DRW Securities's Sonoma Pharmaceuticals position peaked at $222K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.